156 related articles for article (PubMed ID: 17627237)
1. The dynamics of glucose metabolism under calcineurin inhibitors in the first year after renal transplantation in nonobese patients.
David-Neto E; Lemos FC; Fadel LM; Agena F; Sato MY; Coccuza C; Pereira LM; de Castro MC; Lando VS; Nahas WC; Ianhez LE
Transplantation; 2007 Jul; 84(1):50-5. PubMed ID: 17627237
[TBL] [Abstract][Full Text] [Related]
2. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors.
van den Hoogen MW; van der Hoeven AM; Hilbrands LB
Exp Clin Transplant; 2013 Jun; 11(3):234-8. PubMed ID: 23432070
[TBL] [Abstract][Full Text] [Related]
3. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
Handisurya A; Kerscher C; Tura A; Herkner H; Payer BA; Mandorfer M; Werzowa J; Winnicki W; Reiberger T; Kautzky-Willer A; Pacini G; Säemann M; Schmidt A
PLoS One; 2016; 11(1):e0145319. PubMed ID: 26735686
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
van Duijnhoven EM; Christiaans MHL; Boots JMM; Nieman FHM; Wolffenbuttel BHR; van Hooff JP
J Am Soc Nephrol; 2002 Jan; 13(1):213-220. PubMed ID: 11752040
[TBL] [Abstract][Full Text] [Related]
5. Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period.
Havrdova T; Jedinakova T; Lipar K; Skibova J; Saudek F
Transplant Proc; 2011 Nov; 43(9):3270-2. PubMed ID: 22099774
[TBL] [Abstract][Full Text] [Related]
6. Preserved insulin secretion and kidney function in recipients with functional pancreas grafts 1 year after transplantation: a single-center prospective observational study.
Nordheim E; Birkeland KI; Åsberg A; Hartmann A; Horneland R; Jenssen T
Eur J Endocrinol; 2018 Oct; 179(4):251-259. PubMed ID: 30299895
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of insulin resistance after renal transplantation in patients on triple immunosuppressive therapy with cyclosporine, corticosteroids and mycophenolate mofetil.
Petkovska L; Ivanovski N; Dimitrovski C; Serafimoski V
Prilozi; 2008 Jul; 29(1):129-39. PubMed ID: 18709005
[TBL] [Abstract][Full Text] [Related]
8. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
[TBL] [Abstract][Full Text] [Related]
10. Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
Gelens MA; Christiaans MH; van Hooff JP
Nephrol Dial Transplant; 2008 Feb; 23(2):701-6. PubMed ID: 17999993
[TBL] [Abstract][Full Text] [Related]
11. No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure.
Gelens MACJ; van Hooff JP; Usvyat L; Christiaans MH
J Diabetes Complications; 2017 Sep; 31(9):1384-1388. PubMed ID: 28720321
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation.
Dmitrewski J; Krentz AJ; Mayer AD; Buckels JA; Barnes AD; Smith J; Nattrass M
Diabetes Obes Metab; 2001 Aug; 3(4):287-92. PubMed ID: 11520309
[TBL] [Abstract][Full Text] [Related]
13. Conversion from tacrolimus to cyclosporin is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation.
Bouchta NB; Ghisdal L; Abramowicz D; Broeders N; Surquin M; Hoang AD; Wissing KM
Transplant Proc; 2005 May; 37(4):1857-60. PubMed ID: 15919485
[TBL] [Abstract][Full Text] [Related]
14. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
Araki M; Flechner SM; Ismail HR; Flechner LM; Zhou L; Derweesh IH; Goldfarb D; Modlin C; Novick AC; Faiman C
Transplantation; 2006 Feb; 81(3):335-41. PubMed ID: 16477217
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers.
Øzbay LA; Møller N; Juhl C; Bjerre M; Carstens J; Rungby J; Jørgensen KA
Br J Clin Pharmacol; 2012 Apr; 73(4):536-45. PubMed ID: 21988494
[TBL] [Abstract][Full Text] [Related]
16. Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus.
Dieterle CD; Schmauss S; Veitenhansl M; Gutt B; Illner WD; Land W; Landgraf R
Transplantation; 2004 May; 77(10):1561-5. PubMed ID: 15239622
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
[TBL] [Abstract][Full Text] [Related]
18. Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study.
Bang JB; Oh CK; Kim YS; Kim SH; Yu HC; Kim CD; Ju MK; So BJ; Lee SH; Han SY; Jung CW; Kim JK; Lee SH; Jeon JY
Endocrinol Metab (Seoul); 2020 Dec; 35(4):820-829. PubMed ID: 33202516
[TBL] [Abstract][Full Text] [Related]
19. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
20. Pancreata from pediatric donors restore insulin independence in adult insulin-dependent diabetes mellitus recipients.
Socci C; Orsenigo E; Santagostino I; Caumo A; Caldara R; Parolini D; Aldrighetti L; Castoldi R; Frasson M; Carvello M; Ghirardelli L; Secchi A; Di Carlo V; Staudacher C
Transplant Proc; 2010; 42(6):2068-70. PubMed ID: 20692410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
